• Workday Adaptive Planning

  Participated · Equity · Jun 2015

  Adaptive Insights offers a cloud-based finance suite for budgeting, forecasting, reporting, consolidation, dashboards, and business intelligence. The Adaptive Suite is sold direct and through a cloud CPM channel ecosystem of 200+ partners, including Accenture, Armanino, BDO, KPMG and others, and is also offered by NetSuite as its Financial Planning Module. Led by CEO Tom Bogan, the company serves 2,700 customers in 85 countries across midsized companies, nonprofits, and large corporations (including AAA, Boston Scientific, Konica Minolta, Philips, and Siemens). The company plans to use the new funding to accelerate product innovation and global expansion. Its partner and channel strategy includes major professional services and ERP partners that help distribute the product. The suite focuses on finance teams and corporate performance management workflows. Adaptive Planning delivers cloud-based corporate performance management (CPM) and business intelligence (BI) products for companies and nonprofits. Its product suite includes Adaptive Consolidation for financial consolidation and analysis and Adaptive Discovery for visual analytics, interactive data visualization, and alerting. The company’s solutions are used by over 1,600 organizations worldwide, including customers such as AAA, Boston Scientific, CORT, Konica Minolta, NetSuite, Philips, and Vail Resorts. Adaptive also works with worldwide partners—Armanino McKenna, Intacct, IntuitiveTek, Plex Systems, SAP, and NetSuite—that offer a specialized version as the NetSuite Financial Planning module. Led by CEO John Herr, the company plans to continue product development and expand its market reach. The article does not disclose revenue figures. Adaptive Planning offers a cloud-based SaaS corporate performance management platform that lets finance, sales, HR and other management teams plan, monitor, report on and analyze financial and operational performance. Its platform includes budgeting, forecasting, reporting, consolidation, dashboards and business intelligence capabilities. The service is used by over 1,200 organizations worldwide, including customers such as AAA, Boston Scientific, CORT, Konica Minolta, NetSuite, Philips and Vail Resorts. Led by CEO John Herr, the company serves midsized companies, nonprofits and large corporations. Adaptive Planning is hiring and is focused on expanding its market presence.

• Verdezyne

  Participated · Equity · Apr 2014

  Verdezyne is an industrial biotechnology company based in Carlsbad, California, and Kuala Lumpur, Malaysia, that uses proven and proprietary metabolic pathway engineering tools to develop unique yeast strains for cost-effective production of bio-based chemicals. Its core product offering is renewable chemicals produced via engineered yeast rather than petroleum-derived feedstocks. The company plans to accelerate technology development in the U.S. and to support collaborative projects with Sime Darby Renewables. Management researched the oil palm industry with assistance from the Malaysian Biotechnology Corporation and positions Sime Darby as a partner to help lead the development of sustainable palm-based materials into higher-value downstream renewable products. Verdezyne has arranged a $48 million financing led by Sime Darby and joined by existing investors BP Alternative Energy Ventures, DSM Venturing B.V., OVP Venture Partners and Monitor Ventures. The financing was formalized at a signing ceremony in Kuala Lumpur attended by U.S. President Barack Obama and Malaysian Prime Minister Dato' Sri Najib Razak. Verdezyne is an industrial biotechnology company using proven and proprietary metabolic pathway engineering tools to create unique yeast strains for cost-effective production of biobased fuels and chemicals. Its platform has been advanced for the company’s ethanol and adipic acid processes. The company is building yeast metabolic engineering capabilities to produce a pipeline of renewable transportation fuels and platform chemicals. New financing will allow Verdezyne to continue development and deployment of first-in-class engineered yeast strains. Company executives and investors characterized the funding as strategic validation from industry leaders. Current investors include BP, DSM, OVP Venture Partners, Monitor Ventures, Life Science Angels and Tech Coast Angels. Verdezyne develops fermentation processes for industrial chemicals and biofuels using synthetic biology. The company applies proprietary computational and bioinformatics programs to create highly diverse directed mutant gene libraries. These libraries are intended to enhance metabolic engineering tools and serve as a platform for protein and metabolic engineering. Verdezyne says the enhanced capability will be directly useful to life science researchers and to its internal biofuel and biobased chemical programs. The company received a $1.7M grant from the National Institute of Allergy and Infectious Diseases to advance this work over an 18-month period. Verdezyne is based in Carlsbad, California.

• IVT

  Participated · Series B · Feb 2010

  IVT provides enterprise-friendly webcasting software delivered as a SaaS offering that powers live and on-demand webcasts. Its platform also converts multimedia files, such as slideshows, into viewable videos for the web. IVT operates a YouTube-like hosting and social media site to help companies disseminate videos and webcasts. The company counts prominent corporate customers including Oracle, Dow Chemical, IBM and NEC. IVT has been commercializing its webcasting and video-hosting stack across large enterprises and media workflows. Financially, the company has completed multiple institutional financings, including a prior Series A in 2006.

No current team members are available.